|
US2524855A
(en)
|
|
1950-10-10 |
|
Process for the manufacture of |
|
CA722109A
(en)
|
|
1965-11-23 |
W. Mock Henry |
Extrusion of ethylene oxide polymers
|
|
US2806033A
(en)
|
1955-08-03 |
1957-09-10 |
Lewenstein |
Morphine derivative
|
|
US2987445A
(en)
|
1958-10-10 |
1961-06-06 |
Rohm & Haas |
Drug composition
|
|
US3370035A
(en)
|
1961-06-23 |
1968-02-20 |
Takeda Chemical Industries Ltd |
Stabilization of polyalkylene oxide
|
|
US3332950A
(en)
|
1963-03-23 |
1967-07-25 |
Endo Lab |
14-hydroxydihydronormorphinone derivatives
|
|
GB1147210A
(en)
|
1965-06-30 |
1969-04-02 |
Eastman Kodak Co |
Improvements in or relating to vitamins
|
|
US3652589A
(en)
|
1967-07-27 |
1972-03-28 |
Gruenenthal Chemie |
1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
|
|
US3806603A
(en)
|
1969-10-13 |
1974-04-23 |
W Gaunt |
Pharmaceutical carriers of plasticized dried milled particles of hydrated cooked rice endosperm
|
|
CH503520A
(de)
|
1969-12-15 |
1971-02-28 |
Inventa Ag |
Verfahren zum Vermahlen von körnigen Materialien, insbesondere von Kunststoffgranulaten, bei tiefen Temperaturen
|
|
DE2210071A1
(de)
|
1971-03-09 |
1972-09-14 |
PPG Industries Inc., Pittsburgh, Pa. (V.StA.) |
Verfahren zum Auftragen und Härten einer Vielzahl von Überzügen
|
|
US3865108A
(en)
|
1971-05-17 |
1975-02-11 |
Ortho Pharma Corp |
Expandable drug delivery device
|
|
US3966747A
(en)
|
1972-10-26 |
1976-06-29 |
Bristol-Myers Company |
9-Hydroxy-6,7-benzomorphans
|
|
US4014965A
(en)
|
1972-11-24 |
1977-03-29 |
The Dow Chemical Company |
Process for scrapless forming of plastic articles
|
|
US3980766A
(en)
|
1973-08-13 |
1976-09-14 |
West Laboratories, Inc. |
Orally administered drug composition for therapy in the treatment of narcotic drug addiction
|
|
US3941865A
(en)
|
1973-12-10 |
1976-03-02 |
Union Carbide Corporation |
Extrusion of ethylene oxide resins
|
|
US4002173A
(en)
|
1974-07-23 |
1977-01-11 |
International Paper Company |
Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
|
|
DE2530563C2
(de)
|
1975-07-09 |
1986-07-24 |
Bayer Ag, 5090 Leverkusen |
Analgetische Arzneimittel mit vermindertem Mißbrauchspotential
|
|
JPS603286B2
(ja)
|
1977-03-03 |
1985-01-26 |
日本化薬株式会社 |
定速溶出性製剤
|
|
US4207893A
(en)
|
1977-08-29 |
1980-06-17 |
Alza Corporation |
Device using hydrophilic polymer for delivering drug to biological environment
|
|
US4175119A
(en)
|
1978-01-11 |
1979-11-20 |
Porter Garry L |
Composition and method to prevent accidental and intentional overdosage with psychoactive drugs
|
|
DE2822324C3
(de)
|
1978-05-22 |
1981-02-26 |
Basf Ag, 6700 Ludwigshafen |
Herstellung von Vitamin-E-Trockenpulver
|
|
US4211681A
(en)
|
1978-08-16 |
1980-07-08 |
Union Carbide Corporation |
Poly(ethylene oxide) compositions
|
|
US4200704A
(en)
|
1978-09-28 |
1980-04-29 |
Union Carbide Corporation |
Controlled degradation of poly(ethylene oxide)
|
|
NO793297L
(no)
|
1978-10-19 |
1980-04-22 |
Mallinckrodt Inc |
Fremgangsmaate til fremstilling av oksymorfon
|
|
US4258027A
(en)
|
1979-03-26 |
1981-03-24 |
Mead Johnson & Company |
Multi-fractionable tablet structure
|
|
US4215104A
(en)
|
1979-03-26 |
1980-07-29 |
Mead Johnson & Company |
Multi-fractionable tablet structure
|
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4353887A
(en)
|
1979-08-16 |
1982-10-12 |
Ciba-Geigy Corporation |
Divisible tablet having controlled and delayed release of the active substance
|
|
CH648754A5
(en)
|
1979-08-16 |
1985-04-15 |
Ciba Geigy Ag |
Pharmaceutical slow release tablet
|
|
US4457933A
(en)
|
1980-01-24 |
1984-07-03 |
Bristol-Myers Company |
Prevention of analgesic abuse
|
|
JPS56169622A
(en)
|
1980-06-03 |
1981-12-26 |
Kissei Pharmaceut Co Ltd |
Method of making solid preparation from oily substance
|
|
DE3024416C2
(de)
|
1980-06-28 |
1982-04-15 |
Gödecke AG, 1000 Berlin |
Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
|
|
US4473640A
(en)
|
1982-06-03 |
1984-09-25 |
Combie Joan D |
Detection of morphine and its analogues using enzymatic hydrolysis
|
|
US4462941A
(en)
|
1982-06-10 |
1984-07-31 |
The Regents Of The University Of California |
Dynorphin amide analogs
|
|
US4427778A
(en)
|
1982-06-29 |
1984-01-24 |
Biochem Technology, Inc. |
Enzymatic preparation of particulate cellulose for tablet making
|
|
US4485211A
(en)
|
1982-09-15 |
1984-11-27 |
The B. F. Goodrich Company |
Poly(glycidyl ether)block copolymers and process for their preparation
|
|
US4427681A
(en)
|
1982-09-16 |
1984-01-24 |
Richardson-Vicks, Inc. |
Thixotropic compositions easily convertible to pourable liquids
|
|
US4529583A
(en)
|
1983-03-07 |
1985-07-16 |
Clear Lake Development Group |
Composition and method of immobilizing emetics and method of treating human beings with emetics
|
|
US4603143A
(en)
|
1983-05-02 |
1986-07-29 |
Basf Corporation |
Free-flowing, high density, fat soluble vitamin powders with improved stability
|
|
US4612008A
(en)
|
1983-05-11 |
1986-09-16 |
Alza Corporation |
Osmotic device with dual thermodynamic activity
|
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
|
US5082668A
(en)
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
|
US4599342A
(en)
|
1984-01-16 |
1986-07-08 |
The Procter & Gamble Company |
Pharmaceutical products providing enhanced analgesia
|
|
US4629621A
(en)
|
1984-07-23 |
1986-12-16 |
Zetachron, Inc. |
Erodible matrix for sustained release bioactive composition
|
|
AU592065B2
(en)
|
1984-10-09 |
1990-01-04 |
Dow Chemical Company, The |
Sustained release dosage form based on highly plasticized cellulose ether gels
|
|
GB8507779D0
(en)
|
1985-03-26 |
1985-05-01 |
Fujisawa Pharmaceutical Co |
Drug carrier
|
|
US4774092A
(en)
|
1985-06-24 |
1988-09-27 |
Ici Australia Limited |
Ingestible capsules
|
|
EP0328775B1
(en)
|
1985-06-28 |
1993-10-20 |
Carrington Laboratories, Inc. |
Processes for preparation of aloe products, products produced thereby and compositions thereof
|
|
US4992279A
(en)
|
1985-07-03 |
1991-02-12 |
Kraft General Foods, Inc. |
Sweetness inhibitor
|
|
US4851521A
(en)
|
1985-07-08 |
1989-07-25 |
Fidia, S.P.A. |
Esters of hyaluronic acid
|
|
EP0226061B1
(en)
|
1985-12-17 |
1994-02-16 |
United States Surgical Corporation |
High molecular weight bioresorbable polymers and implantation devices thereof
|
|
US5229164A
(en)
|
1985-12-19 |
1993-07-20 |
Capsoid Pharma Gmbh |
Process for producing individually dosed administration forms
|
|
US4711894A
(en)
|
1986-01-16 |
1987-12-08 |
Henkel Corporation |
Stabilized tocopherol in dry, particulate, free-flowing form
|
|
US4940556A
(en)
|
1986-01-30 |
1990-07-10 |
Syntex (U.S.A.) Inc. |
Method of preparing long acting formulation
|
|
US5198226A
(en)
|
1986-01-30 |
1993-03-30 |
Syntex (U.S.A.) Inc. |
Long acting nicardipine hydrochloride formulation
|
|
US4764378A
(en)
|
1986-02-10 |
1988-08-16 |
Zetachron, Inc. |
Buccal drug dosage form
|
|
JPS62232433A
(ja)
|
1986-03-31 |
1987-10-12 |
ユニオン、カ−バイド、コ−ポレ−シヨン |
アルキレンオキシド重合用触媒の製造方法
|
|
DE3612211A1
(de)
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Kontinuierliches verfahren zum tablettieren
|
|
US4667013A
(en)
|
1986-05-02 |
1987-05-19 |
Union Carbide Corporation |
Process for alkylene oxide polymerization
|
|
US4713243A
(en)
|
1986-06-16 |
1987-12-15 |
Johnson & Johnson Products, Inc. |
Bioadhesive extruded film for intra-oral drug delivery and process
|
|
USRE33093E
(en)
|
1986-06-16 |
1989-10-17 |
Johnson & Johnson Consumer Products, Inc. |
Bioadhesive extruded film for intra-oral drug delivery and process
|
|
USRE34990E
(en)
|
1986-08-07 |
1995-07-04 |
Ciba-Geigy Corporation |
Oral therapeutic system having systemic action
|
|
CA1335748C
(en)
|
1986-09-25 |
1995-05-30 |
Jeffrey Lawrence Finnan |
Crosslinked gelatins
|
|
US5227157A
(en)
|
1986-10-14 |
1993-07-13 |
Board Of Regents, The University Of Texas System |
Delivery of therapeutic agents
|
|
WO1988003408A1
(en)
|
1986-11-10 |
1988-05-19 |
Biopure Corporation |
Extra pure semi-synthetic blood substitute
|
|
US4892889A
(en)
|
1986-11-18 |
1990-01-09 |
Basf Corporation |
Process for making a spray-dried, directly-compressible vitamin powder comprising unhydrolyzed gelatin
|
|
JPH0831303B2
(ja)
|
1986-12-01 |
1996-03-27 |
オムロン株式会社 |
チツプ型ヒユ−ズ
|
|
ATE72111T1
(de)
|
1987-01-14 |
1992-02-15 |
Ciba Geigy Ag |
Therapeutisches system fuer schwerloesliche wirkstoffe.
|
|
US4892778A
(en)
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
|
US5051261A
(en)
|
1987-11-24 |
1991-09-24 |
Fmc Corporation |
Method for preparing a solid sustained release form of a functionally active composition
|
|
JP2719020B2
(ja)
|
1987-12-17 |
1998-02-25 |
ジ・アップジョン・カンパニー |
三本の溝付き錠剤
|
|
DE3812567A1
(de)
|
1988-04-15 |
1989-10-26 |
Basf Ag |
Verfahren zur herstellung pharmazeutischer mischungen
|
|
US4954346A
(en)
|
1988-06-08 |
1990-09-04 |
Ciba-Geigy Corporation |
Orally administrable nifedipine solution in a solid light resistant dosage form
|
|
US4960814A
(en)
|
1988-06-13 |
1990-10-02 |
Eastman Kodak Company |
Water-dispersible polymeric compositions
|
|
US5350741A
(en)
|
1988-07-30 |
1994-09-27 |
Kanji Takada |
Enteric formulations of physiologically active peptides and proteins
|
|
JPH0249719A
(ja)
|
1988-08-11 |
1990-02-20 |
Dai Ichi Kogyo Seiyaku Co Ltd |
易水分散・可溶性能を有する油溶性ビタミン粉末
|
|
GB8820327D0
(en)
|
1988-08-26 |
1988-09-28 |
May & Baker Ltd |
New compositions of matter
|
|
DE3830353A1
(de)
|
1988-09-07 |
1990-03-15 |
Basf Ag |
Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
|
|
US5139790A
(en)
|
1988-10-14 |
1992-08-18 |
Zetachron, Inc. |
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
|
US5004601A
(en)
|
1988-10-14 |
1991-04-02 |
Zetachron, Inc. |
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
|
US4957668A
(en)
|
1988-12-07 |
1990-09-18 |
General Motors Corporation |
Ultrasonic compacting and bonding particles
|
|
US5190760A
(en)
|
1989-07-08 |
1993-03-02 |
Coopers Animal Health Limited |
Solid pharmaceutical composition
|
|
US5169645A
(en)
|
1989-10-31 |
1992-12-08 |
Duquesne University Of The Holy Ghost |
Directly compressible granules having improved flow properties
|
|
US5200197A
(en)
|
1989-11-16 |
1993-04-06 |
Alza Corporation |
Contraceptive pill
|
|
GB8926612D0
(en)
|
1989-11-24 |
1990-01-17 |
Erba Farmitalia |
Pharmaceutical compositions
|
|
EP0449775A3
(en)
|
1990-03-29 |
1992-09-02 |
Ciba-Geigy Ag |
Polyether-polyester block copolymers and their use as dispersing agents
|
|
SU1759445A1
(ru)
|
1990-06-15 |
1992-09-07 |
Ленинградский Технологический Институт Им.Ленсовета |
Способ получени капсулированных гидрофобных веществ
|
|
FR2664851B1
(fr)
|
1990-07-20 |
1992-10-16 |
Oreal |
Procede de compactage d'un melange pulverulent permettant d'obtenir un produit compact absorbant ou partiellement delitable et produit obtenu par ce procede.
|
|
EP0477135A1
(en)
|
1990-09-07 |
1992-03-25 |
Warner-Lambert Company |
Chewable spheroidal coated microcapsules and methods for preparing same
|
|
US5126151A
(en)
|
1991-01-24 |
1992-06-30 |
Warner-Lambert Company |
Encapsulation matrix
|
|
US5273758A
(en)
|
1991-03-18 |
1993-12-28 |
Sandoz Ltd. |
Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
|
|
US5149538A
(en)
|
1991-06-14 |
1992-09-22 |
Warner-Lambert Company |
Misuse-resistive transdermal opioid dosage form
|
|
JP3073054B2
(ja)
|
1991-07-11 |
2000-08-07 |
住友精化株式会社 |
アルキレンオキシド重合体の製造方法
|
|
DE69231856T2
(de)
|
1991-08-30 |
2002-03-28 |
Showa Pharm Chem Ind |
Trockene gelzusammensetzung
|
|
WO1993006821A1
(en)
|
1991-10-04 |
1993-04-15 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained-release tablet
|
|
WO1993006723A1
(en)
|
1991-10-04 |
1993-04-15 |
Olin Corporation |
Fungicide tablet
|
|
DE4138513A1
(de)
|
1991-11-23 |
1993-05-27 |
Basf Ag |
Feste pharmazeutische retardform
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
ATE140620T1
(de)
|
1991-12-05 |
1996-08-15 |
Mallinckrodt Veterinary Inc |
Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe
|
|
US5200194A
(en)
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
|
ES2109377T3
(es)
|
1991-12-18 |
1998-01-16 |
Warner Lambert Co |
Proceso para la preparacion de una dispersion solida.
|
|
US5225417A
(en)
|
1992-01-21 |
1993-07-06 |
G. D. Searle & Co. |
Opioid agonist compounds
|
|
IL105553A
(en)
|
1992-05-06 |
1998-01-04 |
Janssen Pharmaceutica Inc |
Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
|
|
WO1993024110A1
(de)
|
1992-05-22 |
1993-12-09 |
Gödecke Aktiengesellschaft |
Verfahren zur herstellung retardierter arzneimittelzubereitungen
|
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
DE4227385A1
(de)
|
1992-08-19 |
1994-02-24 |
Kali Chemie Pharma Gmbh |
Pankreatinmikropellets
|
|
DE4229085C2
(de)
|
1992-09-01 |
1996-07-11 |
Boehringer Mannheim Gmbh |
Längliche, teilbare Tablette
|
|
US6436441B1
(en)
|
1992-09-18 |
2002-08-20 |
Yamanouchi Pharmaceutical Co., Ltd. |
Hydrogel-forming sustained-release preparation
|
|
US5472943A
(en)
|
1992-09-21 |
1995-12-05 |
Albert Einstein College Of Medicine Of Yeshiva University, |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
|
|
FI101039B
(fi)
|
1992-10-09 |
1998-04-15 |
Eeva Kristoffersson |
Menetelmä lääkepellettien valmistamiseksi
|
|
AU679937B2
(en)
|
1992-11-18 |
1997-07-17 |
Johnson & Johnson Consumer Products, Inc. |
Extrudable compositions for topical or transdermal drug delivery
|
|
KR100297541B1
(ko)
|
1992-12-13 |
2001-11-26 |
마티에우 디올라이티 |
방출제어형약학적제형의제조방법및이방법에의해제조된약학적제형
|
|
GB2273874A
(en)
|
1992-12-31 |
1994-07-06 |
Pertti Olavi Toermaelae |
Preparation of pharmaceuticals in a polymer matrix
|
|
US6071970A
(en)
|
1993-02-08 |
2000-06-06 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
US5914132A
(en)
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
DE4309528C2
(de)
|
1993-03-24 |
1998-05-20 |
Doxa Gmbh |
Folie oder Folienschlauch aus Casein, Verfahren zu deren Herstellung und deren Verwendung
|
|
NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
|
IL109944A
(en)
|
1993-07-01 |
1998-12-06 |
Euro Celtique Sa |
Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms
|
|
DE4329794C2
(de)
|
1993-09-03 |
1997-09-18 |
Gruenenthal Gmbh |
Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
|
|
EP2036558A3
(en)
|
1993-10-07 |
2010-04-28 |
Euro-Celtique S.A. |
Orally administrable opioid formulations having extended duration of effect
|
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
|
PT654263E
(pt)
|
1993-11-23 |
2002-06-28 |
Euro Celtique Sa |
Metodo para a preparacao de uma composicao de libertyacao prolongada
|
|
AU1266895A
(en)
|
1993-12-20 |
1995-07-10 |
Procter & Gamble Company, The |
Process for making laxatives containing dioctyl sulfosuccinate
|
|
IL112106A0
(en)
|
1993-12-22 |
1995-03-15 |
Ergo Science Inc |
Accelerated release composition containing bromocriptine
|
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
ATE241962T1
(de)
|
1994-02-16 |
2003-06-15 |
Abbott Lab |
Verfahren zur herstellung feinteiliger pharmazeutischer formulierungen
|
|
SE9503924D0
(sv)
|
1995-08-18 |
1995-11-07 |
Astra Ab |
Novel opioid peptides
|
|
US5458887A
(en)
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
|
DE4413350A1
(de)
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
|
PT758244E
(pt)
|
1994-05-06 |
2002-04-29 |
Pfizer |
Formas de dosagem libertacao controlada de azitromicina
|
|
DE19509807A1
(de)
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
|
|
AT403988B
(de)
|
1994-05-18 |
1998-07-27 |
Lannacher Heilmittel |
Festes orales retardpräparat
|
|
US5460826A
(en)
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
|
DE4426245A1
(de)
|
1994-07-23 |
1996-02-22 |
Gruenenthal Gmbh |
1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
|
|
IT1274879B
(it)
|
1994-08-03 |
1997-07-25 |
Saitec Srl |
Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
|
|
JP3285452B2
(ja)
|
1994-08-11 |
2002-05-27 |
サンスター株式会社 |
歯磨組成物
|
|
US5837790A
(en)
|
1994-10-24 |
1998-11-17 |
Amcol International Corporation |
Precipitation polymerization process for producing an oil adsorbent polymer capable of entrapping solid particles and liquids and the product thereof
|
|
AUPM897594A0
(en)
|
1994-10-25 |
1994-11-17 |
Daratech Pty Ltd |
Controlled release container
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
DE4446470A1
(de)
|
1994-12-23 |
1996-06-27 |
Basf Ag |
Verfahren zur Herstellung von teilbaren Tabletten
|
|
DE19504832A1
(de)
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
|
US5945125A
(en)
|
1995-02-28 |
1999-08-31 |
Temple University |
Controlled release tablet
|
|
US6117453A
(en)
|
1995-04-14 |
2000-09-12 |
Pharma Pass |
Solid compositions containing polyethylene oxide and an active ingredient
|
|
US6348469B1
(en)
|
1995-04-14 |
2002-02-19 |
Pharma Pass Llc |
Solid compositions containing glipizide and polyethylene oxide
|
|
US5900425A
(en)
|
1995-05-02 |
1999-05-04 |
Bayer Aktiengesellschaft |
Pharmaceutical preparations having controlled release of active compound and processes for their preparation
|
|
DE19522899C1
(de)
|
1995-06-23 |
1996-12-19 |
Hexal Pharmaforschung Gmbh |
Verfahren zum kontinuierlichen Ersintern eines Granulats
|
|
US5759583A
(en)
|
1995-08-30 |
1998-06-02 |
Syntex (U.S.A.) Inc. |
Sustained release poly (lactic/glycolic) matrices
|
|
US6063405A
(en)
|
1995-09-29 |
2000-05-16 |
L.A.M. Pharmaceuticals, Llc |
Sustained release delivery system
|
|
US5811126A
(en)
|
1995-10-02 |
1998-09-22 |
Euro-Celtique, S.A. |
Controlled release matrix for pharmaceuticals
|
|
DE19539361A1
(de)
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
|
US5908850A
(en)
|
1995-12-04 |
1999-06-01 |
Celgene Corporation |
Method of treating attention deficit disorders with d-threo methylphenidate
|
|
US6355656B1
(en)
|
1995-12-04 |
2002-03-12 |
Celgene Corporation |
Phenidate drug formulations having diminished abuse potential
|
|
DE19547766A1
(de)
|
1995-12-20 |
1997-06-26 |
Gruenenthal Gmbh |
1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
|
|
PT914097E
(pt)
|
1996-03-12 |
2002-06-28 |
Alza Corp |
Composicao e forma de dosagem compreendendo antagonista de opioide
|
|
US6461644B1
(en)
|
1996-03-25 |
2002-10-08 |
Richard R. Jackson |
Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
|
|
US20020114838A1
(en)
|
1996-04-05 |
2002-08-22 |
Ayer Atul D. |
Uniform drug delivery therapy
|
|
DK0914158T4
(da)
|
1996-04-05 |
2006-03-06 |
Takeda Pharmaceutical |
Farmaceutisk kombination indeholdende en forbindelse med angiotensin II antagonistisk aktivitet og en forbindelse, der öger insulin-sensitiviteten
|
|
US6096339A
(en)
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
|
US5817343A
(en)
|
1996-05-14 |
1998-10-06 |
Alkermes, Inc. |
Method for fabricating polymer-based controlled-release devices
|
|
BR9709535A
(pt)
|
1996-06-06 |
2000-01-11 |
Bifodan As |
Composição para formação de um revestimento entérico em uma preparação oral,preparação oral provida com um revestmento entérico,e , processo para a preparação de um revestimento entérico em uma preparação oral contendo bactérias vivas
|
|
AU3508097A
(en)
|
1996-06-26 |
1998-01-14 |
Board Of Regents, The University Of Texas System |
Hot-melt extrudable pharmaceutical formulation
|
|
AU695734B2
(en)
|
1996-07-08 |
1998-08-20 |
Penwest Pharmaceuticals Co. |
Sustained release matrix for high-dose insoluble drugs
|
|
DE19629753A1
(de)
|
1996-07-23 |
1998-01-29 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
|
NL1003684C2
(nl)
|
1996-07-25 |
1998-01-28 |
Weterings B V H |
Inrichting voor het afgeven van een vloeistof.
|
|
DE19630236A1
(de)
|
1996-07-26 |
1998-01-29 |
Wolff Walsrode Ag |
Biaxial gereckte, biologisch abbaubare und kompostierbare Wursthülle
|
|
BE1010353A5
(fr)
|
1996-08-14 |
1998-06-02 |
Boss Pharmaceuticals Ag |
Procede pour la fabrication de produits pharmaceutiques, dispositif pour un tel procede et produits pharmaceutiques ainsi obtenus.
|
|
DE69731396C5
(de)
|
1996-11-05 |
2013-10-31 |
Novamont S.P.A. |
Biologisch abbaubare Polymerzusammensetzungen, die Stärke und ein thermoplastisches Polymer enthalten
|
|
US5991799A
(en)
|
1996-12-20 |
1999-11-23 |
Liberate Technologies |
Information retrieval system using an internet multiplexer to focus user selection
|
|
DE19705538C1
(de)
|
1997-02-14 |
1998-08-27 |
Goedecke Ag |
Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
DE19710213A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Verfahren zur Herstellung von festen Kombinationsarzneiformen
|
|
DE19710009A1
(de)
|
1997-03-12 |
1998-09-24 |
Knoll Ag |
Mehrphasige wirkstoffhaltige Zubereitungsformen
|
|
DE19710008A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
|
|
US6139770A
(en)
|
1997-05-16 |
2000-10-31 |
Chevron Chemical Company Llc |
Photoinitiators and oxygen scavenging compositions
|
|
DE19721467A1
(de)
|
1997-05-22 |
1998-11-26 |
Basf Ag |
Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
|
|
WO1998055107A1
(en)
|
1997-06-06 |
1998-12-10 |
Depomed, Inc. |
Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
EP1009387B1
(en)
|
1997-07-02 |
2006-04-12 |
Euro-Celtique S.A. |
Stabilized sustained release tramadol formulations
|
|
IE970588A1
(en)
|
1997-08-01 |
2000-08-23 |
Elan Corp Plc |
Controlled release pharmaceutical compositions containing tiagabine
|
|
WO1999012864A1
(en)
|
1997-09-10 |
1999-03-18 |
Alliedsignal Inc. |
Injection molding of structural zirconia-based materials by an aqueous process
|
|
US6009390A
(en)
|
1997-09-11 |
1999-12-28 |
Lucent Technologies Inc. |
Technique for selective use of Gaussian kernels and mixture component weights of tied-mixture hidden Markov models for speech recognition
|
|
ES2174538T3
(es)
|
1997-11-28 |
2002-11-01 |
Knoll Ag |
Procedimiento para la obtencion de substancias exentas de disolventes, no cristalinas, biologicamente activas.
|
|
EP1036107A1
(de)
|
1997-12-03 |
2000-09-20 |
Basf Aktiengesellschaft |
Polyetheresteramide
|
|
DE19753534A1
(de)
|
1997-12-03 |
1999-06-10 |
Bayer Ag |
Schnell kristallisierende, biologisch abbaubare Polyesteramide
|
|
CN1204890C
(zh)
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
DE19800698A1
(de)
|
1998-01-10 |
1999-07-15 |
Bayer Ag |
Biologisch abbaubare Polyesteramide mit blockartig aufgebauten Polyester- und Polyamid-Segmenten
|
|
DE19800689C1
(de)
|
1998-01-10 |
1999-07-15 |
Deloro Stellite Gmbh |
Formkörper aus einem verschleißfesten Werkstoff
|
|
US6251430B1
(en)
|
1998-02-04 |
2001-06-26 |
Guohua Zhang |
Water insoluble polymer based sustained release formulation
|
|
AU2587299A
(en)
|
1998-02-06 |
1999-08-23 |
Union Carbide Chemicals & Plastics Technology Corporation |
Alkylene oxide polymer compositions
|
|
US6235825B1
(en)
|
1998-03-05 |
2001-05-22 |
Mitsui Chemicals, Inc. |
Polylactic acid resin composition and film therefrom
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6090411A
(en)
|
1998-03-09 |
2000-07-18 |
Temple University |
Monolithic tablet for controlled drug release
|
|
US6110500A
(en)
|
1998-03-25 |
2000-08-29 |
Temple University |
Coated tablet with long term parabolic and zero-order release kinetics
|
|
JP2002510878A
(ja)
|
1998-04-02 |
2002-04-09 |
アプライド マテリアルズ インコーポレイテッド |
低ｋ誘電体をエッチングする方法
|
|
CA2327685C
(en)
|
1998-04-03 |
2008-11-18 |
Bm Research A/S |
Controlled release composition
|
|
US5962488A
(en)
|
1998-04-08 |
1999-10-05 |
Roberts Laboratories, Inc. |
Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
|
|
DE19822979A1
(de)
|
1998-05-25 |
1999-12-02 |
Kalle Nalo Gmbh & Co Kg |
Folie mit Stärke oder Stärkederivaten und Polyesterurethanen sowie Verfahren zu ihrer Herstellung
|
|
US6333087B1
(en)
|
1998-08-27 |
2001-12-25 |
Chevron Chemical Company Llc |
Oxygen scavenging packaging
|
|
DE19841244A1
(de)
|
1998-09-09 |
2000-03-16 |
Knoll Ag |
Verfahren und Vorrichtung zum Herstellen von Tabletten
|
|
GT199900148A
(es)
|
1998-09-10 |
2001-02-28 |
|
Desnaturalizantes para las sales aminas simpaticomimeticas.
|
|
US6268177B1
(en)
|
1998-09-22 |
2001-07-31 |
Smithkline Beecham Corporation |
Isolated nucleic acid encoding nucleotide pyrophosphorylase
|
|
WO2000023073A1
(en)
|
1998-10-20 |
2000-04-27 |
Korea Institute Of Science And Technology |
Bioflavonoids as plasma high density lipoprotein level increasing agent
|
|
US20010055613A1
(en)
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
|
US20060240105A1
(en)
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
|
ES2141688B1
(es)
|
1998-11-06 |
2001-02-01 |
Vita Invest Sa |
Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
|
|
DE19855440A1
(de)
|
1998-12-01 |
2000-06-08 |
Basf Ag |
Verfahren zum Herstellen fester Darreichungsformen mittels Schmelzextrusion
|
|
EP1005863A1
(en)
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
DE19856147A1
(de)
|
1998-12-04 |
2000-06-08 |
Knoll Ag |
Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
|
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
|
US6238697B1
(en)
|
1998-12-21 |
2001-05-29 |
Pharmalogix, Inc. |
Methods and formulations for making bupropion hydrochloride tablets using direct compression
|
|
WO2000040205A2
(en)
|
1999-01-05 |
2000-07-13 |
Copley Pharmaceutical Inc. |
Sustained release formulation with reduced moisture sensitivity
|
|
CA2321107A1
(en)
|
1999-02-04 |
2000-08-10 |
Nichimo Co., Ltd. |
Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6375963B1
(en)
|
1999-06-16 |
2002-04-23 |
Michael A. Repka |
Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
|
|
US6384020B1
(en)
|
1999-07-14 |
2002-05-07 |
Shire Laboratories, Inc. |
Rapid immediate release oral dosage form
|
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
|
JP2003522127A
(ja)
|
1999-07-29 |
2003-07-22 |
ロクセニ ラボラトリーズ インコーポレイテッド |
オピオイド徐放性製剤
|
|
PT1205190E
(pt)
|
1999-08-04 |
2006-09-29 |
Astellas Pharma Inc |
Composicoes medicinais estaveis para uso oral utilizando oxidos de ferro
|
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
|
KR100345214B1
(ko)
|
1999-08-17 |
2002-07-25 |
이강춘 |
생체적합성 고분자가 수식된 펩타이드의 비점막 전달
|
|
DE19940944B4
(de)
|
1999-08-31 |
2006-10-12 |
Grünenthal GmbH |
Retardierte, orale, pharmazeutische Darreichungsformen
|
|
ATE279186T1
(de)
|
1999-08-31 |
2004-10-15 |
Gruenenthal Gmbh |
Retardierte darreichungsform enthaltend tramadolsaccharinat
|
|
DE19940740A1
(de)
|
1999-08-31 |
2001-03-01 |
Gruenenthal Gmbh |
Pharmazeutische Salze
|
|
DE19960494A1
(de)
|
1999-12-15 |
2001-06-21 |
Knoll Ag |
Vorrichtung und Verfahren zum Herstellen von festen wirkstoffhaltigen Formen
|
|
ES2160534B1
(es)
|
1999-12-30 |
2002-04-16 |
Vita Invest Sa |
Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
|
|
US6680070B1
(en)
|
2000-01-18 |
2004-01-20 |
Albemarle Corporation |
Particulate blends and compacted products formed therefrom, and the preparation thereof
|
|
ES2539904T3
(es)
|
2000-02-08 |
2015-07-07 |
Euro-Celtique S.A. |
Formulaciones orales de agonistas opioides resistentes a manipulaciones indebidas
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
DE10015479A1
(de)
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
|
US8012504B2
(en)
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
|
US6572887B2
(en)
|
2000-05-01 |
2003-06-03 |
National Starch And Chemical Investment Holding Corporation |
Polysaccharide material for direct compression
|
|
US6419954B1
(en)
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
|
US6890751B2
(en)
|
2000-05-23 |
2005-05-10 |
Acorda Therapeutics, Inc. |
NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
|
DE10029201A1
(de)
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
|
US6607748B1
(en)
|
2000-06-29 |
2003-08-19 |
Vincent Lenaerts |
Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
|
|
DE10036400A1
(de)
|
2000-07-26 |
2002-06-06 |
Mitsubishi Polyester Film Gmbh |
Weiße, biaxial orientierte Polyesterfolie
|
|
WO2002026262A2
(en)
|
2000-09-25 |
2002-04-04 |
Pro-Pharmaceuticals, Inc. |
Compositions for reducing side effects in chemotherapeutic treatments
|
|
JP2004509634A
(ja)
|
2000-09-27 |
2004-04-02 |
ダニスコ エイ／エス |
抗菌剤
|
|
AU2001294902A1
(en)
|
2000-09-28 |
2002-04-08 |
The Dow Chemical Company |
Polymer composite structures useful for controlled release systems
|
|
GB0026137D0
(en)
|
2000-10-25 |
2000-12-13 |
Euro Celtique Sa |
Transdermal dosage form
|
|
US6344215B1
(en)
|
2000-10-27 |
2002-02-05 |
Eurand America, Inc. |
Methylphenidate modified release formulations
|
|
AU2002226098A1
(en)
|
2000-10-30 |
2002-05-15 |
The Board Of Regents, The University Of Texas System |
Spherical particles produced by a hot-melt extrusion/spheronization process
|
|
IL155637A0
(en)
|
2000-10-30 |
2003-11-23 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
|
DE10109763A1
(de)
|
2001-02-28 |
2002-09-05 |
Gruenenthal Gmbh |
Pharmazeutische Salze
|
|
JP2002265592A
(ja)
|
2001-03-07 |
2002-09-18 |
Sumitomo Seika Chem Co Ltd |
アルキレンオキシド重合体の製造方法
|
|
WO2002071860A1
(en)
|
2001-03-13 |
2002-09-19 |
L.A. Dreyfus Co. |
Gum base and gum manufacturing using particulated gum base ingredients
|
|
JP3967554B2
(ja)
|
2001-03-15 |
2007-08-29 |
株式会社ポッカコーポレーション |
フラボノイド化合物及びその製造方法
|
|
EP1241110A1
(en)
|
2001-03-16 |
2002-09-18 |
Pfizer Products Inc. |
Dispensing unit for oxygen-sensitive drugs
|
|
US20020132395A1
(en)
|
2001-03-16 |
2002-09-19 |
International Business Machines Corporation |
Body contact in SOI devices by electrically weakening the oxide under the body
|
|
EP1385486A4
(en)
|
2001-04-18 |
2006-05-17 |
Nostrum Pharmaceuticals Inc |
NEW COATING OF SLOW RELEASE PHARMACEUTICAL COMPOSITION
|
|
US20020187192A1
(en)
|
2001-04-30 |
2002-12-12 |
Yatindra Joshi |
Pharmaceutical composition which reduces or eliminates drug abuse potential
|
|
JP4481569B2
(ja)
|
2001-05-01 |
2010-06-16 |
ユニオン カーバイド ケミカルズ アンド プラスティックス テクノロジー エルエルシー |
ギ酸化合物の量を減らしたポリ（アルキレンオキシド）
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
US6852891B2
(en)
|
2001-05-08 |
2005-02-08 |
The Johns Hopkins University |
Method of inhibiting methaphetamine synthesis
|
|
DE60216078T2
(de)
|
2001-05-11 |
2007-07-05 |
Endo Pharmaceuticals Inc. |
Opioid enthaltende arzneiform gegen missbrauch
|
|
DE60238756D1
(de)
|
2001-05-11 |
2011-02-10 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
|
US6623754B2
(en)
|
2001-05-21 |
2003-09-23 |
Noveon Ip Holdings Corp. |
Dosage form of N-acetyl cysteine
|
|
WO2002094172A2
(en)
|
2001-05-22 |
2002-11-28 |
Euro-Celtique |
Compartmentalized dosage form
|
|
US20030064122A1
(en)
|
2001-05-23 |
2003-04-03 |
Endo Pharmaceuticals, Inc. |
Abuse resistant pharmaceutical composition containing capsaicin
|
|
US7968119B2
(en)
|
2001-06-26 |
2011-06-28 |
Farrell John J |
Tamper-proof narcotic delivery system
|
|
US20030008409A1
(en)
|
2001-07-03 |
2003-01-09 |
Spearman Steven R. |
Method and apparatus for determining sunlight exposure
|
|
EP1404333A1
(en)
|
2001-07-06 |
2004-04-07 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
|
DE60223254T2
(de)
|
2001-07-06 |
2008-08-14 |
Penwest Pharmaceuticals Co. |
Verzögert freisetzende formulierungen von oxymorphon
|
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
|
JP2003020517A
(ja)
|
2001-07-10 |
2003-01-24 |
Calp Corp |
複合繊維用樹脂組成物
|
|
EP1416842B1
(en)
|
2001-07-18 |
2008-12-31 |
Euro-Celtique S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
|
US6883976B2
(en)
|
2001-07-30 |
2005-04-26 |
Seikoh Giken Co., Ltd. |
Optical fiber ferrule assembly and optical module and optical connector using the same
|
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
|
JP2005500364A
(ja)
|
2001-08-06 |
2005-01-06 |
ユーロ−セルティーク，エス．エイ． |
オピオイドの乱用を防止する組成物と方法
|
|
US7157103B2
(en)
|
2001-08-06 |
2007-01-02 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing irritant
|
|
AU2002321879A1
(en)
|
2001-08-06 |
2003-03-03 |
Thomas Gruber |
Pharmaceutical formulation containing dye
|
|
US7144587B2
(en)
|
2001-08-06 |
2006-12-05 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
|
|
US7141250B2
(en)
|
2001-08-06 |
2006-11-28 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing bittering agent
|
|
AU2002324624A1
(en)
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
|
JP2005501067A
(ja)
|
2001-08-06 |
2005-01-13 |
ユーロ−セルティーク，エス．エイ． |
オピオイドの乱用を防ぐための組成物および方法
|
|
JP3474870B2
(ja)
|
2001-08-08 |
2003-12-08 |
菱計装株式会社 |
昇降機
|
|
US20030049272A1
(en)
|
2001-08-30 |
2003-03-13 |
Yatindra Joshi |
Pharmaceutical composition which produces irritation
|
|
US6691698B2
(en)
|
2001-09-14 |
2004-02-17 |
Fmc Technologies Inc. |
Cooking oven having curved heat exchanger
|
|
US20030059467A1
(en)
|
2001-09-14 |
2003-03-27 |
Pawan Seth |
Pharmaceutical composition comprising doxasozin
|
|
US20030059397A1
(en)
|
2001-09-17 |
2003-03-27 |
Lyn Hughes |
Dosage forms
|
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
|
US20030092724A1
(en)
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
|
DE60224293T2
(de)
|
2001-09-21 |
2008-12-11 |
Egalet A/S |
Feste dispersionen mit kontrollierter freisetzung von carvedilol
|
|
WO2003028698A2
(de)
|
2001-09-26 |
2003-04-10 |
Steffens Klaus-Juergen |
Verfahren und vorrichtung zur herstellung von granulaten umfassend mindestens einen pharmazeutischen wirkstoff
|
|
US20030091635A1
(en)
|
2001-09-26 |
2003-05-15 |
Baichwal Anand R. |
Opioid formulations having reduced potential for abuse
|
|
US6837696B2
(en)
|
2001-09-28 |
2005-01-04 |
Mcneil-Ppc, Inc. |
Apparatus for manufacturing dosage forms
|
|
BR0206086A
(pt)
|
2001-09-28 |
2003-12-23 |
Mcneil Ppc Inc |
Formas de dosagem de liberação modificada
|
|
WO2003031546A1
(en)
|
2001-10-09 |
2003-04-17 |
The Procter & Gamble Company |
Aqueous compositions for treating a surface
|
|
US6592901B2
(en)
|
2001-10-15 |
2003-07-15 |
Hercules Incorporated |
Highly compressible ethylcellulose for tableting
|
|
JP2003125706A
(ja)
|
2001-10-23 |
2003-05-07 |
Lion Corp |
口中清涼製剤
|
|
PE20030527A1
(es)
|
2001-10-24 |
2003-07-26 |
Gruenenthal Chemie |
Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
|
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US20030152622A1
(en)
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030104052A1
(en)
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
ES2663873T3
(es)
|
2001-10-29 |
2018-04-17 |
Massachusetts Institute Of Technology |
Forma farmacéutica con perfil de liberación de orden cero fabricada por impresión tridimensional
|
|
US20030125347A1
(en)
|
2001-11-02 |
2003-07-03 |
Elan Corporation Plc |
Pharmaceutical composition
|
|
US20040126428A1
(en)
|
2001-11-02 |
2004-07-01 |
Lyn Hughes |
Pharmaceutical formulation including a resinate and an aversive agent
|
|
US20030175345A1
(en)
|
2001-12-06 |
2003-09-18 |
Hite Michael P. |
Isoflavone composition for oral delivery
|
|
FR2833838B1
(fr)
|
2001-12-21 |
2005-09-16 |
Ellipse Pharmaceuticals |
Procede de fabrication d'un comprime incluant un analgesique de type morphinique et comprime obtenu
|
|
AUPS044502A0
(en)
|
2002-02-11 |
2002-03-07 |
Commonwealth Scientific And Industrial Research Organisation |
Novel catalysts and processes for their preparation
|
|
US20040033253A1
(en)
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
|
US20030158265A1
(en)
|
2002-02-20 |
2003-08-21 |
Ramachandran Radhakrishnan |
Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same
|
|
US20030190343A1
(en)
|
2002-03-05 |
2003-10-09 |
Pfizer Inc. |
Palatable pharmaceutical compositions for companion animals
|
|
US6572889B1
(en)
|
2002-03-07 |
2003-06-03 |
Noveon Ip Holdings Corp. |
Controlled release solid dosage carbamazepine formulations
|
|
US6753009B2
(en)
|
2002-03-13 |
2004-06-22 |
Mcneil-Ppc, Inc. |
Soft tablet containing high molecular weight polyethylene oxide
|
|
EP2316428A1
(en)
|
2002-04-05 |
2011-05-04 |
Euro-Celtique S.A. |
Matrix for sustained, invariant and independent release of active compounds
|
|
DE10217232B4
(de)
|
2002-04-18 |
2004-08-19 |
Ticona Gmbh |
Verfahren zur Herstellung gefüllter Granulate aus Polyethylenen hohen bzw. ultrahohen Molekulargewichts
|
|
WO2003089506A1
(en)
|
2002-04-22 |
2003-10-30 |
Purdue Research Foundation |
Hydrogels having enhanced elasticity and mechanical strength properties
|
|
RU2004134594A
(ru)
|
2002-04-29 |
2005-06-27 |
Алза Корпорейшн (Us) |
Способы и лекарственные формы для контролируемой доставки оксикодона
|
|
US20050106249A1
(en)
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
|
CA2486075A1
(en)
|
2002-05-13 |
2003-11-20 |
Endo Pharmaceuticals Inc. |
Abuse-resistant opioid solid dosage form
|
|
MXPA04012021A
(es)
|
2002-05-31 |
2005-08-16 |
Johnson & Johnson |
Formas de dosis y composiciones para la administracion osmotica de dosis variables de oxicodona.
|
|
DE10250083A1
(de)
|
2002-06-17 |
2003-12-24 |
Gruenenthal Gmbh |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
US7399488B2
(en)
|
2002-07-05 |
2008-07-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
|
US20040011806A1
(en)
|
2002-07-17 |
2004-01-22 |
Luciano Packaging Technologies, Inc. |
Tablet filler device with star wheel
|
|
AR040680A1
(es)
|
2002-07-25 |
2005-04-13 |
Pharmacia Corp |
Composicion de tabletas de liberacion sostenida
|
|
US7388068B2
(en)
|
2002-08-21 |
2008-06-17 |
Clariant Produkte (Deutschland) Gmbh |
Copolymers made of alkylene oxides and glycidyl ethers and use thereof as polymerizable emulsifiers
|
|
JP2006501234A
(ja)
|
2002-08-21 |
2006-01-12 |
フォークス ファーマシューティカルズ リミテッド |
錠剤製造における、クエン酸およびラクチトール等の水溶性糖水溶液の、造粒液としての使用
|
|
US20040052844A1
(en)
|
2002-09-16 |
2004-03-18 |
Fang-Hsiung Hsiao |
Time-controlled, sustained release, pharmaceutical composition containing water-soluble resins
|
|
JP2006506353A
(ja)
|
2002-09-17 |
2006-02-23 |
ワイス |
経口処方
|
|
PL215110B1
(pl)
|
2002-09-20 |
2013-10-31 |
Fmc Corp |
Kompozycja nadajaca sie do rozpylania
|
|
ATE386509T1
(de)
|
2002-09-21 |
2008-03-15 |
Shuyi Zhang |
Formulierung von acetaminophen und tramadol mit verzögerter freisetzung
|
|
JP5189242B2
(ja)
|
2002-09-23 |
2013-04-24 |
アルケルメス ファーマ アイルランド リミテッド |
乱用抵抗性の医薬組成物
|
|
JP2004143071A
(ja)
|
2002-10-23 |
2004-05-20 |
Hosokawa Funtai Gijutsu Kenkyusho:Kk |
薬物含有複合粒子の製造方法および薬物含有複合粒子
|
|
DE10250084A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE10250087A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US20050186139A1
(en)
|
2002-10-25 |
2005-08-25 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE10250088A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US20050191244A1
(en)
|
2002-10-25 |
2005-09-01 |
Gruenenthal Gmbh |
Abuse-resistant pharmaceutical dosage form
|
|
PT1594460E
(pt)
|
2002-10-25 |
2008-06-27 |
Labopharm Inc |
Formulações de tramadol de libertação sustentada com eficácia durante 24 horas
|
|
DE10252667A1
(de)
|
2002-11-11 |
2004-05-27 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
US20040091528A1
(en)
|
2002-11-12 |
2004-05-13 |
Yamanouchi Pharma Technologies, Inc. |
Soluble drug extended release system
|
|
US7018658B2
(en)
|
2002-11-14 |
2006-03-28 |
Synthon Bv |
Pharmaceutical pellets comprising tamsulosin
|
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
US7442387B2
(en)
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
|
EP1603597B1
(en)
|
2003-03-13 |
2010-01-06 |
Controlled Chemicals, Inc. |
Oxycodone conjugates with lower abuse potential and extended duration of action
|
|
WO2004084869A1
(en)
|
2003-03-26 |
2004-10-07 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
|
US8877241B2
(en)
|
2003-03-26 |
2014-11-04 |
Egalet Ltd. |
Morphine controlled release system
|
|
US9579286B2
(en)
|
2003-04-21 |
2017-02-28 |
Purdue Pharma L.P. |
Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same
|
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
|
ME00276B
(me)
|
2003-04-30 |
2011-05-10 |
Purdue Pharma Lp |
Transdermalni dozni oblik otporan na promjene koje sadrže komponentu aktivnog sredstva i komponentu suprotnog sredstva na mjestu koji je ispod sloja aktivnog sredstva
|
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
|
CN1473562A
(zh)
|
2003-06-27 |
2004-02-11 |
辉 刘 |
儿用口腔速溶、速崩冻干片及其制备方法
|
|
HU227142B1
(en)
|
2003-07-02 |
2010-08-30 |
Egis Gyogyszergyar Nyilvanosan |
Capsule of improved release containing fluconazole
|
|
US20050015730A1
(en)
|
2003-07-14 |
2005-01-20 |
Srimanth Gunturi |
Systems, methods and computer program products for identifying tab order sequence of graphically represented elements
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE102004020220A1
(de)
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
CL2004002016A1
(es)
|
2003-08-06 |
2005-05-20 |
Gruenenthal Chemie |
Forma de dosificacion termoformada a prueba de abuso que contiene (a) uno o mas principios activos susceptibles de abuso, (b) opcionalmente sustancias auxiliares, (c) al menos un polimero sintetico o natural definido y (d) opcionalmente al menos una
|
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
PL1842533T3
(pl)
|
2003-08-06 |
2013-08-30 |
Gruenenthal Gmbh |
Postać aplikacyjna zabezpieczona przed nadużyciem
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
RU2339365C2
(ru)
|
2003-08-06 |
2008-11-27 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма
|
|
US20050063214A1
(en)
|
2003-09-22 |
2005-03-24 |
Daisaburo Takashima |
Semiconductor integrated circuit device
|
|
JP4758897B2
(ja)
|
2003-09-25 |
2011-08-31 |
ユーロ−セルティーク エス．エイ． |
ヒドロコドンとナルトレキソンとの併用医薬
|
|
BRPI0414941A
(pt)
|
2003-09-30 |
2006-11-07 |
Alza Corp |
dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente
|
|
US20060172006A1
(en)
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US20060009478A1
(en)
|
2003-10-15 |
2006-01-12 |
Nadav Friedmann |
Methods for the treatment of back pain
|
|
AU2004285547A1
(en)
|
2003-10-29 |
2005-05-12 |
Alza Corporation |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
ES2600577T3
(es)
|
2003-12-04 |
2017-02-09 |
Bend Research, Inc. |
Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
|
|
DE602004005076T2
(de)
|
2003-12-09 |
2007-11-15 |
Euro-Celtique S.A. |
Co-extrudierte sicherheits-dosierform mit einem wirkstoff und einem adversen mittel und herstellungsverfahren dafür
|
|
WO2005060942A1
(en)
|
2003-12-19 |
2005-07-07 |
Aurobindo Pharma Ltd |
Extended release pharmaceutical composition of metformin
|
|
DE10360792A1
(de)
|
2003-12-23 |
2005-07-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
JP2007517061A
(ja)
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
新規薬剤組成物及び投与形態物
|
|
US20070196396A1
(en)
|
2004-02-11 |
2007-08-23 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
|
GB0403100D0
(en)
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Particulates
|
|
GB0403098D0
(en)
|
2004-02-12 |
2004-03-17 |
Euro Celtique Sa |
Extrusion
|
|
TWI350762B
(en)
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
|
BRPI0507210A
(pt)
|
2004-02-23 |
2007-06-12 |
Euro Celtique Sa |
dispositivo que impede o uso indevido para administração transdérmica de opióide
|
|
TW201509943A
(zh)
|
2004-03-30 |
2015-03-16 |
Euro Celtique Sa |
含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
|
JP2005314407A
(ja)
|
2004-03-31 |
2005-11-10 |
Nippon Nohyaku Co Ltd |
新規なハロアルキルスルホンアニリド誘導体、除草剤及びその使用方法並びにその中間体
|
|
US20050220877A1
(en)
|
2004-03-31 |
2005-10-06 |
Patel Ashish A |
Bilayer tablet comprising an antihistamine and a decongestant
|
|
DE102004019916A1
(de)
|
2004-04-21 |
2005-11-17 |
Grünenthal GmbH |
Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
|
|
EP1740156B8
(de)
|
2004-04-22 |
2012-07-11 |
Grünenthal GmbH |
Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
|
|
WO2005105036A1
(en)
|
2004-04-28 |
2005-11-10 |
Natco Pharma Limited |
Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation
|
|
US20050271594A1
(en)
|
2004-06-04 |
2005-12-08 |
Groenewoud Pieter J |
Abuse resistent pharmaceutical composition
|
|
TWI356036B
(en)
|
2004-06-09 |
2012-01-11 |
Smithkline Beecham Corp |
Apparatus and method for pharmaceutical production
|
|
DE602004007905T2
(de)
|
2004-06-28 |
2008-05-08 |
Grünenthal GmbH |
Kristalline Formen von (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochlorid
|
|
ITMI20041317A1
(it)
|
2004-06-30 |
2004-09-30 |
Ibsa Inst Biochimique Sa |
Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
|
|
KR101204657B1
(ko)
|
2004-07-01 |
2012-11-27 |
그뤼넨탈 게엠베하 |
(1r,2r)-3-(3-디메틸아미노-1-에틸-2-메틸-프로필)-페놀을 함유하는 남용 방지 경구 투여 제형
|
|
WO2006002883A1
(de)
|
2004-07-01 |
2006-01-12 |
Grünenthal GmbH |
Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreichungsform unter verwendung eines planetwalzenextruders
|
|
AU2005259476B2
(en)
|
2004-07-01 |
2010-07-29 |
Gruenenthal Gmbh |
Oral dosage form safeguarded against abuse
|
|
DE102004032103A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
KR20060007225A
(ko)
|
2004-07-19 |
2006-01-24 |
삼성전자주식회사 |
촬상소자 구동제어와 메모리 읽기제어를 이용한 손떨림보정방법 및 이를 적용한 촬영장치
|
|
MX2007001036A
(es)
|
2004-07-27 |
2007-04-12 |
Unilever Nv |
Composiciones para el cuidado del cabello.
|
|
GB2418854B
(en)
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
|
US20070077297A1
(en)
|
2004-09-30 |
2007-04-05 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
|
US20060068009A1
(en)
|
2004-09-30 |
2006-03-30 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
|
US7426948B2
(en)
|
2004-10-08 |
2008-09-23 |
Phibrowood, Llc |
Milled submicron organic biocides with narrow particle size distribution, and uses thereof
|
|
US20060177380A1
(en)
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20070231268A1
(en)
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
SI1849470T1
(sl)
|
2005-01-26 |
2017-10-30 |
Taiho Pharmaceutical Co., Ltd. |
Zdravilo proti raku, ki vsebuje alfa,alfa,alfa-trifluorotimidin in zaviralec timidin-fosforilaze
|
|
EA015615B1
(ru)
|
2005-01-28 |
2011-10-31 |
Еуро-Селтик С.А. |
Устойчивые к спиртам лекарственные формы
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
FR2889810A1
(fr)
|
2005-05-24 |
2007-02-23 |
Flamel Technologies Sa |
Forme medicamenteuse orale, microparticulaire, anti-mesurage
|
|
US7292616B2
(en)
|
2005-02-09 |
2007-11-06 |
Ultratech, Inc. |
CO2 laser stabilization systems and methods
|
|
US20080131503A1
(en)
|
2005-02-10 |
2008-06-05 |
Per Holm |
Stable Pharmaceutical Composition Comprising a Fixed Dose Combination of Fenofibrate and an Hmg-Coa Reductase Inhibitor
|
|
US20060194759A1
(en)
|
2005-02-25 |
2006-08-31 |
Eidelson Stewart G |
Topical compositions and methods for treating pain and inflammation
|
|
EP1695700A1
(en)
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
|
RS51131B
(sr)
|
2005-03-04 |
2010-10-31 |
Euro-Celtique S.A. |
Postupak smanjenja alfa, beta nezasićenih ketona u opioidnim kompozicijama
|
|
US20060204575A1
(en)
|
2005-03-11 |
2006-09-14 |
Hengsheng Feng |
Amphetamine formulations
|
|
US7732427B2
(en)
|
2005-03-31 |
2010-06-08 |
University Of Delaware |
Multifunctional and biologically active matrices from multicomponent polymeric solutions
|
|
WO2006105615A1
(en)
|
2005-04-08 |
2006-10-12 |
Ozpharma Pty Ltd |
Buccal delivery system
|
|
US20100152299A1
(en)
|
2005-05-10 |
2010-06-17 |
Madhav Vasanthavada |
Process for making compositions with poorly compressible therapeutic compounds
|
|
CN101188999B
(zh)
|
2005-06-03 |
2012-07-18 |
尹格莱特股份有限公司 |
用于递送分散在分散介质中的活性物质的药物传递系统
|
|
WO2007005716A2
(en)
|
2005-06-30 |
2007-01-11 |
Cinergen, Llc |
Methods of treatment and compositions for use thereof
|
|
US8221792B2
(en)
|
2005-07-07 |
2012-07-17 |
Farnam Companies, Inc. |
Sustained release pharmaceutical compositions for highly water soluble drugs
|
|
DE102005032806A1
(de)
|
2005-07-12 |
2007-01-18 |
Röhm Gmbh |
Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
|
|
US8858993B2
(en)
|
2005-07-25 |
2014-10-14 |
Metrics, Inc. |
Coated tablet with zero-order or near zero-order release kinetics
|
|
JP4809952B2
(ja)
|
2005-07-29 |
2011-11-09 |
キョーラク株式会社 |
コンテナおよびその製造方法
|
|
AU2006275476A1
(en)
|
2005-08-01 |
2007-02-08 |
Alpharma Inc. |
Alcohol resistant pharmaceutical formulations
|
|
JP2009503071A
(ja)
|
2005-08-03 |
2009-01-29 |
イーストマン ケミカル カンパニー |
トコフェリルポリエチレングリコールスクシネート粉末及びその製造方法
|
|
US20070048373A1
(en)
|
2005-08-30 |
2007-03-01 |
Cima Labs Inc. |
Dried milled granulate and methods
|
|
ATE513842T1
(de)
|
2005-10-14 |
2011-07-15 |
Kitasato Inst |
Neue dihydropseudoerythromycinderivate
|
|
WO2007045462A2
(de)
|
2005-10-19 |
2007-04-26 |
Grünenthal GmbH |
Neue vanilloid-rezeptor liganden und ihre verwendung zur herstellung von arzneimitteln
|
|
US20070092573A1
(en)
|
2005-10-24 |
2007-04-26 |
Laxminarayan Joshi |
Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
US9125833B2
(en)
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
|
US8329744B2
(en)
|
2005-11-02 |
2012-12-11 |
Relmada Therapeutics, Inc. |
Methods of preventing the serotonin syndrome and compositions for use thereof
|
|
US8652529B2
(en)
|
2005-11-10 |
2014-02-18 |
Flamel Technologies |
Anti-misuse microparticulate oral pharmaceutical form
|
|
FR2892937B1
(fr)
|
2005-11-10 |
2013-04-05 |
Flamel Tech Sa |
Forme pharmaceutique orale microparticulaire anti-mesusage
|
|
DE102005058569B4
(de)
|
2005-12-08 |
2010-07-15 |
Lts Lohmann Therapie-Systeme Ag |
Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
|
|
US20090317355A1
(en)
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
EP1991207A2
(en)
|
2006-01-21 |
2008-11-19 |
Abbott GmbH & Co. KG |
Dosage form and method for the delivery of drugs of abuse
|
|
US20100172989A1
(en)
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
EP1813276A1
(en)
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
|
FR2897267A1
(fr)
|
2006-02-16 |
2007-08-17 |
Flamel Technologies Sa |
Formes pharmaceutiques multimicroparticulaires pour administration per os
|
|
ZA200807571B
(en)
|
2006-03-01 |
2009-08-26 |
Ethypharm Sa |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
|
EP2086515A2
(en)
|
2006-03-02 |
2009-08-12 |
Vaunnex, Inc. |
Rate-controlled bioadhesive oral dosage formulations
|
|
CN101395159A
(zh)
|
2006-03-02 |
2009-03-25 |
马林克罗特公司 |
制备含有低含量α,β-不饱和酮化合物的吗啡烷-6-酮产物的方法
|
|
US20070224637A1
(en)
|
2006-03-24 |
2007-09-27 |
Mcauliffe Joseph C |
Oxidative protection of lipid layer biosensors
|
|
WO2007112285A2
(en)
|
2006-03-24 |
2007-10-04 |
Auxilium Pharmaceuticals, Inc. |
Process for the preparation of a hot-melt extruded laminate
|
|
AU2007230730B2
(en)
|
2006-03-24 |
2013-03-28 |
Auxilium International Holdings, Inc. |
Stabilized compositions containing alkaline labile drugs
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
US9023400B2
(en)
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
|
WO2007138466A2
(en)
|
2006-06-01 |
2007-12-06 |
Wockhardt Ltd |
Pharmaceutical compositions comprising meloxicam and tramadol combination
|
|
US20070292508A1
(en)
|
2006-06-05 |
2007-12-20 |
Balchem Corporation |
Orally disintegrating dosage forms
|
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
PT2719378T
(pt)
|
2006-06-19 |
2016-11-02 |
Alpharma Pharmaceuticals Llc |
Composições farmacêuticas
|
|
CN101091721A
(zh)
|
2006-06-22 |
2007-12-26 |
孙明 |
阿胶新剂型的制备方法
|
|
EP2043613A1
(en)
|
2006-07-14 |
2009-04-08 |
Fmc Corporation |
Solid form
|
|
JP4029109B1
(ja)
|
2006-07-18 |
2008-01-09 |
タマ生化学株式会社 |
ビタミンｅとプロリンの複合体粉末及びその製造方法
|
|
EP2068840A2
(en)
|
2006-07-21 |
2009-06-17 |
LAB International SRL |
Hydrophobic abuse deterrent delivery system
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
US8445018B2
(en)
*
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
KR101400824B1
(ko)
|
2006-09-25 |
2014-05-29 |
후지필름 가부시키가이샤 |
레지스트 조성물, 이 레지스트 조성물에 사용되는 수지, 이수지의 합성에 사용되는 화합물, 및 상기 레지스트조성물을 사용한 패턴형성방법
|
|
US8187636B2
(en)
|
2006-09-25 |
2012-05-29 |
Atlantic Pharmaceuticals, Inc. |
Dosage forms for tamper prone therapeutic agents
|
|
US20080085304A1
(en)
|
2006-10-10 |
2008-04-10 |
Penwest Pharmaceuticals Co. |
Robust sustained release formulations
|
|
CN101578096A
(zh)
|
2006-10-10 |
2009-11-11 |
潘威斯脱药物公司 |
稳健的缓释制剂
|
|
GB0624880D0
(en)
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
|
DE102006062120A1
(de)
|
2006-12-22 |
2008-06-26 |
Grünenthal GmbH |
Pharmazeutische Zusammensetzung zur Aknebehandlung
|
|
WO2008079404A2
(en)
|
2006-12-22 |
2008-07-03 |
Combinatorx, Incorporated |
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
|
|
EP2104493A2
(en)
|
2007-01-16 |
2009-09-30 |
Egalet A/S |
Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
WO2008094877A2
(en)
|
2007-01-30 |
2008-08-07 |
Drugtech Corporation |
Compositions for oral delivery of pharmaceuticals
|
|
CN100579525C
(zh)
|
2007-02-02 |
2010-01-13 |
东南大学 |
盐酸尼卡地平缓释制剂及其制备方法
|
|
ATE552861T1
(de)
|
2007-02-08 |
2012-04-15 |
Kempharm Inc |
Polare hydrophile prodrugs von amphetamin und anderen stimulantien sowie herstellungs- und verwendungsverfahren
|
|
CN101057849A
(zh)
|
2007-02-27 |
2007-10-24 |
齐齐哈尔医学院 |
含有盐酸二甲双胍和格列吡嗪的缓释制剂及其制备方法
|
|
AU2008223091B2
(en)
|
2007-03-02 |
2014-04-24 |
Farnam Companies, Inc. |
Sustained release pellets comprising wax-like material
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
EP1980245A1
(en)
|
2007-04-11 |
2008-10-15 |
Cephalon France |
Bilayer lyophilized pharmaceutical compositions and methods of making and using same
|
|
US20080260836A1
(en)
|
2007-04-18 |
2008-10-23 |
Thomas James Boyd |
Films Comprising a Plurality of Polymers
|
|
US8951570B2
(en)
|
2007-04-26 |
2015-02-10 |
Sigmoid Pharma Limited |
Manufacture of multiple minicapsules
|
|
US20110020408A1
(en)
|
2007-05-17 |
2011-01-27 |
Ranbaxy Laboratories Limited |
multilayered modified release formulation comprising amoxicillin and clavulanate
|
|
US8202542B1
(en)
|
2007-05-31 |
2012-06-19 |
Tris Pharma |
Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
|
|
EP2155167A2
(en)
|
2007-06-04 |
2010-02-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
US20100035886A1
(en)
|
2007-06-21 |
2010-02-11 |
Veroscience, Llc |
Parenteral formulations of dopamine agonists
|
|
DE102007030308A1
(de)
|
2007-06-29 |
2009-01-02 |
Printed Systems Gmbh |
Verfahren zum Herstellen einer Speicherstruktur
|
|
CA2690956C
(en)
|
2007-07-01 |
2017-01-03 |
Joseph Peter Habboushe |
Combination tablet with chewable outer layer
|
|
JP2010534204A
(ja)
|
2007-07-20 |
2010-11-04 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
非オピオイド鎮痛薬と閉じ込められたオピオイド鎮痛薬の製剤
|
|
WO2009034541A2
(en)
|
2007-09-11 |
2009-03-19 |
Ranbaxy Laboratories Limited |
Controlled release pharmaceutical dosage forms of trimetazidine
|
|
JP5730572B2
(ja)
|
2007-09-13 |
2015-06-10 |
シマ ラブス インク． |
濫用抵抗性製剤
|
|
US20100303883A1
(en)
|
2007-10-17 |
2010-12-02 |
Axxia Pharmaceuticals, Llc |
Polymeric drug delivery systems and thermoplastic extrusion processes for producing such systems
|
|
CA2706596A1
(en)
|
2007-11-23 |
2009-05-28 |
Protect Pharmaceutical Corporation |
Tapentadol compositions
|
|
JP2011506319A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
|
|
US20100280047A1
(en)
|
2007-12-12 |
2010-11-04 |
Basf Se |
Salts of active ingredients with polymeric counter-ions
|
|
MX2010006694A
(es)
|
2007-12-17 |
2010-09-07 |
Labopharm Inc |
Formulacion de liberacion controlada, preventiva de mal uso.
|
|
BRPI0906467C1
(pt)
|
2008-01-25 |
2021-05-25 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
|
|
KR100970665B1
(ko)
|
2008-02-04 |
2010-07-15 |
삼일제약주식회사 |
알푸조신 또는 그의 염을 함유하는 서방성 정제
|
|
BRPI0909030A2
(pt)
|
2008-03-05 |
2018-03-13 |
Panacea Biotec Ltd |
composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.
|
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
TWI519322B
(zh)
|
2008-04-15 |
2016-02-01 |
愛戴爾製藥股份有限公司 |
包含弱鹼性藥物及控制釋放劑型之組合物
|
|
WO2009135680A1
(en)
|
2008-05-09 |
2009-11-12 |
Grünenthal GmbH |
Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
|
|
CA2729596A1
(en)
|
2008-07-03 |
2010-01-07 |
Novartis Ag |
Melt granulation process
|
|
WO2010022193A2
(en)
|
2008-08-20 |
2010-02-25 |
Board Of Regents, The University Of Texas System |
Hot-melt extrusion of modified release multi-particulates
|
|
FR2936709B1
(fr)
|
2008-10-02 |
2012-05-11 |
Ethypharm Sa |
Comprimes alcoolo-resistants.
|
|
WO2010044842A1
(en)
|
2008-10-16 |
2010-04-22 |
University Of Tennessee Research Foundation |
Tamper resistant oral dosage forms containing an embolizing agent
|
|
US8481620B2
(en)
|
2008-10-24 |
2013-07-09 |
Kao Corporation |
Process for producing resin composition
|
|
KR101631140B1
(ko)
|
2008-10-27 |
2016-06-20 |
알자 코퍼레이션 |
지속 방출형 경구용 아세트아미노펜/트라마돌 제형
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
BRPI0921049A2
(pt)
|
2008-11-14 |
2017-03-28 |
Portola Pharm Inc |
composição sólida para liberação controlada de agentes ativos ionizáveis com solubilidade aquosa pobre a um ph baixo e métodos para uso da mesma
|
|
WO2010066034A1
(en)
|
2008-12-12 |
2010-06-17 |
Paladin Labs Inc. |
Methadone formulation
|
|
CN102316857A
(zh)
|
2008-12-16 |
2012-01-11 |
莱博法姆公司 |
防止误用的控释配方
|
|
NZ594071A
(en)
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
|
DK2393487T3
(en)
|
2009-02-06 |
2017-01-23 |
Egalet Ltd |
Pharmaceutical compositions resistant to abuse
|
|
SI2408436T1
(sl)
|
2009-03-18 |
2017-06-30 |
Evonik Roehm Gmbh |
Farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola, ki uporablja oplaščenje, ki vsebuje nevtralne vinil polimere in ekscipiente
|
|
EP2246063A1
(en)
|
2009-04-29 |
2010-11-03 |
Ipsen Pharma S.A.S. |
Sustained release formulations comprising GnRH analogues
|
|
GB0909680D0
(en)
|
2009-06-05 |
2009-07-22 |
Euro Celtique Sa |
Dosage form
|
|
WO2010149169A2
(en)
|
2009-06-24 |
2010-12-29 |
Egalet A/S |
Controlled release formulations
|
|
WO2011008298A2
(en)
|
2009-07-16 |
2011-01-20 |
Nectid, Inc. |
Novel axomadol dosage forms
|
|
EP2456427B1
(en)
|
2009-07-22 |
2015-03-04 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
|
CN102639118B
(zh)
|
2009-07-22 |
2015-07-29 |
格吕伦塔尔有限公司 |
氧化稳定的抗干扰剂型
|
|
EP2488029B1
(en)
|
2009-09-30 |
2016-03-23 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
WO2011059074A1
(ja)
|
2009-11-13 |
2011-05-19 |
森六ケミカルズ株式会社 |
微粉末の製造方法および同方法で製造された微粉末
|
|
US9320742B2
(en)
|
2009-12-01 |
2016-04-26 |
Noven Pharmaceuticals, Inc. |
Transdermal testosterone device and delivery
|
|
US9579285B2
(en)
|
2010-02-03 |
2017-02-28 |
Gruenenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
|
CN102869261A
(zh)
|
2010-03-01 |
2013-01-09 |
瑞科西有限公司 |
化合物及其治疗应用
|
|
GB201003731D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Immediate/delayed drug delivery
|
|
US20110223244A1
(en)
|
2010-03-09 |
2011-09-15 |
Elan Pharma International Limited |
Alcohol resistant enteric pharmaceutical compositions
|
|
EP3064199B1
(en)
|
2010-04-02 |
2023-12-20 |
Buzzz Pharmaceuticals Limited |
Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
|
|
AU2011236548A1
(en)
|
2010-04-07 |
2012-11-01 |
Lupin Limited |
Controlled release pharmaceutical compositions of tapentadol
|
|
GB201006200D0
(en)
|
2010-04-14 |
2010-06-02 |
Ayanda As |
Composition
|
|
PL2560624T3
(pl)
|
2010-04-23 |
2019-01-31 |
Kempharm, Inc. |
Formulacja terapeutyczna do zmniejszania skutków ubocznych leku
|
|
US20130059010A1
(en)
|
2010-05-14 |
2013-03-07 |
Ethypharm |
Alcohol-resistant oral pharmaceutical form
|
|
FR2960775A1
(fr)
|
2010-06-07 |
2011-12-09 |
Ethypharm Sa |
Microgranules resistants au detournement
|
|
WO2012028318A1
(en)
|
2010-09-02 |
2012-03-08 |
Grünenthal GmbH |
Tamper resistant dosage form comprising an anionic polymer
|
|
BR112013005195A2
(pt)
|
2010-09-02 |
2016-07-12 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação compreendendo um polímero aniônico
|
|
EP2611426B1
(en)
|
2010-09-02 |
2014-06-25 |
Grünenthal GmbH |
Tamper resistant dosage form comprising inorganic salt
|
|
US20120202838A1
(en)
|
2010-11-04 |
2012-08-09 |
Abbott Laboratories |
Drug formulations
|
|
US20120231083A1
(en)
|
2010-11-18 |
2012-09-13 |
The Board Of Trustees Of The University Of Illinois |
Sustained release cannabinoid medicaments
|
|
GB201020895D0
(en)
|
2010-12-09 |
2011-01-26 |
Euro Celtique Sa |
Dosage form
|
|
NZ612996A
(en)
|
2010-12-23 |
2015-05-29 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
AU2012219322A1
(en)
|
2011-02-17 |
2013-05-09 |
QRxPharma Ltd. |
Technology for preventing abuse of solid dosage forms
|
|
EP2680832B1
(en)
|
2011-03-04 |
2019-09-04 |
Grünenthal GmbH |
Aqueous pharmaceutical formulation of tapentadol for oral administration
|
|
HUE049308T2
(hu)
|
2011-04-29 |
2020-09-28 |
Gruenenthal Gmbh |
Tapentadol alkalmazása depresszió és szorongás megelõzésére és kezelésére
|
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
|
EP2714015B1
(en)
|
2011-06-01 |
2017-03-15 |
FMC Corporation |
Controlled release solid dose forms
|
|
WO2013003845A1
(en)
|
2011-06-30 |
2013-01-03 |
Neos Therapeutics, Lp |
Abuse resistant drug forms
|
|
HUE034710T2
(hu)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Visszaéléssel szemben ellenálló, azonnali hatóanyagfelszabadulást biztosító tabletta
|
|
DK2736495T3
(da)
|
2011-07-29 |
2017-11-13 |
Gruenenthal Gmbh |
Misbrugsbestandig tablet som tilvejebringer øjeblikkelig frigivelse af lægemiddel
|
|
US20140206717A1
(en)
|
2011-08-16 |
2014-07-24 |
John Higgins |
Use of inorganic matrix and organic polymer combinations for preparing stable amorphous dispersions
|
|
FR2979242A1
(fr)
|
2011-08-29 |
2013-03-01 |
Sanofi Sa |
Comprime contre l'usage abusif, a base de paracetamol et d'oxycodone
|
|
WO2013050539A2
(en)
|
2011-10-06 |
2013-04-11 |
Grünenthal GmbH |
Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist
|
|
BR112014011504A2
(pt)
|
2011-11-17 |
2017-05-09 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica oral inviolável compreendendo ingrediente farmacologicamente ativo, antagonista opioide e/ou agente aversivo, óxido de polialquileno e polímero aniônico
|
|
AU2012327231B2
(en)
|
2011-12-09 |
2015-09-24 |
Purdue Pharma L.P. |
Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) and polyethylene oxide
|
|
JP2013155124A
(ja)
|
2012-01-30 |
2013-08-15 |
Moriroku Chemicals Co Ltd |
医薬品の原末及びその製造方法
|
|
CA2864949A1
(en)
|
2012-02-28 |
2013-09-06 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
|
WO2013127830A1
(en)
|
2012-02-28 |
2013-09-06 |
Grünenthal GmbH |
Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
|
|
TW201722406A
(zh)
|
2012-03-02 |
2017-07-01 |
羅德製藥公司 |
抗破壞性立即釋出型調製劑類
|
|
EP2838536B1
(en)
|
2012-04-18 |
2017-08-09 |
Mallinckrodt LLC |
Immediate release pharmaceutical compositions with abuse deterrent properties
|
|
WO2013156453A1
(en)
|
2012-04-18 |
2013-10-24 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
|
DK2846835T3
(en)
|
2012-05-11 |
2017-12-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-proof pharmaceutical dosage form containing zinc
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
US20140034885A1
(en)
|
2012-08-01 |
2014-02-06 |
Acura Pharmaceuticals, Inc. |
Stabilization of one-pot methamphetamine synthesis systems
|
|
WO2014032741A1
(en)
|
2012-08-27 |
2014-03-06 |
Evonik Industries Ag |
Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
|
|
US10842752B2
(en)
|
2012-08-27 |
2020-11-24 |
Evonik Operations Gmbh |
Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
|
|
US9463165B2
(en)
|
2012-09-05 |
2016-10-11 |
Teika Pharmaceutical Co., Ltd. |
Granular material for orally fast disintegrating tablets
|
|
WO2014059512A1
(en)
|
2012-10-15 |
2014-04-24 |
Isa Odidi |
Oral drug delivery formulations
|
|
US10420729B2
(en)
|
2013-03-15 |
2019-09-24 |
R.P. Scherer Technologies, Llc |
Abuse resistant capsule
|
|
US9517208B2
(en)
|
2013-03-15 |
2016-12-13 |
Purdue Pharma L.P. |
Abuse-deterrent dosage forms
|
|
EP2968169A1
(en)
|
2013-03-15 |
2016-01-20 |
Mallinckrodt LLC |
Compositions comprising an opioid and an additional active pharmaceutical ingredient for rapid onset and extended duration of analgesia that may be administered without regard to food
|
|
AU2014273226B2
(en)
|
2013-05-29 |
2019-06-27 |
Grunenthal Gmbh |
Tamper resistant dosage form with bimodal release profile
|
|
EP3003279A1
(en)
|
2013-05-29 |
2016-04-13 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
|
CA2817728A1
(en)
|
2013-05-31 |
2014-11-30 |
Pharmascience Inc. |
Abuse deterrent immediate release formulation
|
|
KR20160031526A
(ko)
|
2013-07-12 |
2016-03-22 |
그뤼넨탈 게엠베하 |
에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형
|
|
WO2015023675A2
(en)
|
2013-08-12 |
2015-02-19 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
WO2015048597A1
(en)
|
2013-09-30 |
2015-04-02 |
Daya Drug Discoveries, Inc. |
Prevention of illicit methamphetamine manufacture from pseudoephedrine using food flavor excipients
|
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
|
US10744131B2
(en)
|
2013-12-31 |
2020-08-18 |
Kashiv Biosciences, Llc |
Abuse-resistant drug formulations
|
|
CA2938699A1
(en)
|
2014-02-05 |
2015-08-13 |
Kashiv Pharma Llc |
Abuse-resistant drug formulations with built-in overdose protection
|
|
US20160089439A1
(en)
|
2014-09-28 |
2016-03-31 |
Satara Pharmaceuticals, LLC |
Prevention of Illicit Manufacutre of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients
|
|
US20170112766A1
(en)
|
2015-04-24 |
2017-04-27 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
|
CA2983642A1
(en)
|
2015-04-24 |
2016-10-27 |
Grunenthal Gmbh |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
|
US20170296476A1
(en)
|
2016-04-15 |
2017-10-19 |
Grünenthal GmbH |
Modified release abuse deterrent dosage forms
|